Exclusive: Bioniq Lands a US$150 Million Maximum Exit as Herbalife Moves Into Precision Nutrition

By Tamara Pupic | Mar 26, 2026
Bioniq

You're reading Entrepreneur Middle East, an international franchise of Entrepreneur Media.

Bioniq, a UK-headquartered personalized supplements company leveraging blood biomarker analysis to tailor nutrition, has been acquired by US global wellness brand Herbalife Ltd for up to US$150 million.

The agreement for the sale of its assets to Herbalife Ltd is expected to close in the second quarter of 2026, subject to customary closing conditions and regulatory approvals. 

The US$55 million purchase price will be paid over five years, including an initial payment of US$10 million at closing. In addition, the transaction value includes up to US$95 million of contingent payments based on future performance.

Vadim Fedotov, co-founder and President, Bioniq, plans to join Herbalife’s leadership team after the transaction.

As part of the transaction, Herbalife also obtained a call option to acquire Bioniq LAB, a separate platform focused on small molecules and peptides. The call option provides Herbalife with strategic flexibility to evaluate potential longer-term opportunities in this area in a disciplined and capital-efficient manner. 

Bioniq’s personalized nutritional supplements are expected to be offered later this year through Herbalife independent distributors for customers in select countries in Europe and the United States, with additional markets to follow.  

The acquisition will enable Bioniq’s science-driven, personalized supplementation platform to scale globally through Herbalife’s extensive infrastructure, which spans 95 markets, with over 2 million distributors and millions of customers worldwide.

Bioniq is backed by prominent investors, including HV Capital and Unbound, as well as elite athletes Cristiano Ronaldo and Diogo Dalot.

“Throughout my career, biometrics and personalized nutrition have been central to helping me perform and compete at the highest level. As a longtime Herbalife and Bioniq user, I’ve experienced firsthand how a tailored approach to nutrition can help optimize performance,” said Cristiano Ronaldo. “I’m delighted to see Bioniq’s personalized supplements become part of Herbalife’s expanding access to nutritional supplements, helping people take a more informed approach to their health, wellness and performance.”

Since entering the UAE in 2021, Bioniq has expanded rapidly across the Gulf region through partnerships with the Department of Culture and Tourism – Abu Dhabi and Al Borg Diagnostics in Saudi Arabia.“With a professional athletic career behind me, I created Bioniq to make health measurable, actionable, and accessible,” said Vadim Fedotov, co-founder and President, Bioniq. “Our science-driven approach, proven efficacy, and sustainable business model have positioned us as a leader in personalized nutrition. Joining Herbalife allows us to accelerate our mission and bring personalized health solutions to a global audience at scale.”

Bioniq, a UK-headquartered personalized supplements company leveraging blood biomarker analysis to tailor nutrition, has been acquired by US global wellness brand Herbalife Ltd for up to US$150 million.

The agreement for the sale of its assets to Herbalife Ltd is expected to close in the second quarter of 2026, subject to customary closing conditions and regulatory approvals. 

The US$55 million purchase price will be paid over five years, including an initial payment of US$10 million at closing. In addition, the transaction value includes up to US$95 million of contingent payments based on future performance.

Related Content